Active Ingredient: TOFACITINIB CITRATE
Proprietary Name: XELJANZ XR
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: EQ 22MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N208246
Product Number: 002
Approval Date: Dec 12, 2019
Applicant Holder Full Name: PFIZER INC
Marketing Status:
Prescription
Patent and Exclusivity Information